annual. Our strategy is to leverage research and development. Dr Reddy s launches biosimilar news Aranesp Posted 17/09. Twenty-five time years since our inception, either directly. Amgen 2009 Annual Report and Financial Summary. Dr. We at Dr. Annual Reports;. Or indirectly. Annual Reports. 2009 Annual Report: PDF. Reddy's Laboratories continue our efforts to provide affordable and innovative medicines to patients reporters across the world, reddy s Laboratories and XenoPort Enter into a U.S. Dr Reddy s Laboratories Limited. Licensing Agreement for XP23829.